Latest Commercialisation News

D3 Energy has expanded its helium resource base significantly in South Africa, certifying a maiden contingent resource at ER386 that boosts combined helium resources by 65%. The company also certified its first Australian prospective resource and started drilling at Nooitgedacht in ER315.

Battery Age Minerals has identified multiple priority exploration targets at its Apex Project in Utah, submitted new drilling permits for Austria’s Bleiberg site, finalised a commercial germanium technology licence, and gained entry to a US defense consortium, underpinning its integrated germanium strategy.

Carnegie Clean Energy has made substantial progress on its ACHIEVE Programme, including module assembly and regulatory approvals for ocean deployment in Spain, supported by a $2.5 million private placement to fund commercial expansion.

Hiremii Limited ended FY26 with its strongest quarter yet, reporting positive adjusted EBITDA, record gross profit, and a strategic rebrand to AQYR focused on AI-powered workforce intelligence.

NuEnergy Gas Limited has locked in a fully funded US$88 million contract with PT Beijing Energy Linking to develop its Tanjung Enim POD 1 project in Indonesia, targeting first gas sales in early 2027 under an Early Gas Sales Initiative.

NeuroScientific Biopharmaceuticals achieved an 80% clinical response rate in fistulising Crohn’s disease patients treated under the TGA Special Access Scheme, advancing plans for Phase 2 trials and manufacturing scale-up.

InVert Graphite has acquired RapidGraphite and its RapidPulse™ technology, aiming to revolutionise graphite processing with rapid, acid-free purification. The company raised A$2.5 million to fund scale-up trials and integrate this with its Morogoro graphite project in Tanzania.

Dotz Nano has appointed Nati Harpaz as CEO, introduced Dotz Energy to extend its decarbonisation efforts, and secured $3.3 million in fresh funding to accelerate commercialisation and production scale-up.

LTR Pharma’s SPONTAN shows rapid absorption in Phase II interim data while securing key US commercial deals for ROXUS, setting the stage for a US market entry later this year.

dorsaVi has unveiled Sensor v6.5, its first wearable sensor that processes and acts on movement data in real time without cloud reliance, marking a key milestone in wearable Physical AI technology.

Wide Open Agriculture (ASX: WOA) is executing a major strategic pivot by closing its German production site and transitioning to a capital-light contract manufacturing model to improve economics and scale lupin protein production.

Argent BioPharma has eliminated US$5.5 million in secured debt through a global licensing agreement for its CannEpil® epilepsy therapy, while completing a key acquisition and advancing clinical trials in veterinary therapeutics.